In July, London-based GlaxoSmithKline (GSK) announced they would be exploring Apple’s ResearchKit, a software toolbox to turn iPhones and Apple Watches into data-harvesting tools for clinical trials. GSK has not yet specified which programs are under consideration, but vice president of clinical pharmacology sciences and study operations Rob DiCicco anticipates some degree of deployment within the next 12 months. He hopes that ResearchKit will allow clinical trial participants to get involved in studies in a way that’s “more aligned with their daily life and less disruptive than it might otherwise be.”
Toggle navigation